Cell-cycle dependence of induced hemoglobin synthesis in Friend erythroleukemia cells temperature-sensitive for growth. 1981

D Conkie, and P R Harrison, and J Paul

Friend erythroleukemia cells temperature-sensitive (ts) for growth have been used to study the cell-cycle dependence of erythroid differentiation. ts cells accumulated hemoglobin in response to inducer when replicating optimally at permissive temperatures. However, when arrested in the G1 phase of the cell cycle at a nonpermissive temperature, ts cells did not accumulate hemoglobin or globin mRNA nor did they differentiate terminally. Under these conditions, the viability of ts cells treated with inducer at the nonpermissive temperature remained high (70% of that of cells induced at the permissive temperature) as judged by cloning experiments. Total RNA and protein synthesis of G1 cells treated with inducer was 44-48% of that of randomly proliferating induced cells, in contrast to thymidine incorporation into DNA which decreased to 2% of that of cells replicating at the permissive temperature. Furthermore, G1 ts cells treated with inducer accumulated hemoglobin when released from growth arrest at the permissive temperature in the presence (but not in the absence) of inducer. These results are consistent with a requirement for a cell cycle-dependent event prior to commitment to differentiation.

UI MeSH Term Description Entries
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004915 Leukemia, Erythroblastic, Acute A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood. Di Guglielmo's Disease,Erythremic Myelosis,Erythroblastic Leukemia, Acute,Erythroleukemia,Leukemia, Myeloid, Acute, M6,Myeloid Leukemia, Acute, M6,Di Guglielmo Disease,Acute Erythroblastic Leukemia,Acute Erythroblastic Leukemias,Di Guglielmos Disease,Disease, Di Guglielmo,Disease, Di Guglielmo's,Erythremic Myeloses,Erythroblastic Leukemias, Acute,Erythroleukemias,Leukemia, Acute Erythroblastic,Leukemias, Acute Erythroblastic,Myeloses, Erythremic,Myelosis, Erythremic
D005622 Friend murine leukemia virus A strain of Murine leukemia virus (LEUKEMIA VIRUS, MURINE) producing leukemia of the reticulum-cell type with massive infiltration of liver, spleen, and bone marrow. It infects DBA/2 and Swiss mice. Friend Virus,Rowson-Parr Virus,Rowson Parr Virus,Virus, Friend,Virus, Rowson-Parr

Related Publications

D Conkie, and P R Harrison, and J Paul
April 1980, Experimental cell research,
D Conkie, and P R Harrison, and J Paul
August 1978, Experimental cell research,
D Conkie, and P R Harrison, and J Paul
February 1990, Kidney international,
D Conkie, and P R Harrison, and J Paul
January 1991, Acta haematologica,
D Conkie, and P R Harrison, and J Paul
August 1993, Biochemical and biophysical research communications,
D Conkie, and P R Harrison, and J Paul
October 1984, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!